Immunodeficiency following hereditary defective response to Epstein-Barr virus

PheWeb

D3_IMMUDEFPOSTEBV

No definition available.

Endpoint definition

↥

FinnGen phenotype data

individuals

Apply sex-specific rule None

Check conditions None

Filter registries

Hospital Discharge: ICD-10 D82.3

Hospital discharge: ICD-9 $!$

Hospital discharge: ICD-8 $!$

Cause of death: ICD-10 D82.3

Cause of death: ICD-9 $!$

Cause of death: ICD-8 $!$

Check pre-conditions, main-only, mode, ICD version

Look only at ICD versions H.D: 10, 8, 9 ; C.O.D: 10, 8, 9

Check minimum number of events None

Include endpoints None

D3_IMMUDEFPOSTEBV

Extra metadata

Level in the ICD hierarchy 4

First used in FinnGen datafreeze DF2

Parent code in ICD-10 D82

Name in latin Deficientia immunalis cum responso defectivo contra agentem viralem Epstein-Barr

Similar endpoints

↥

List of similar endpoints to Immunodeficiency following hereditary defective response to Epstein-Barr virus based on the number of shared cases.

Broader endpoints:

None

Narrower endpoints:

None

Show all endpoint correlations

Summary Statistics

↥

Key figures

All

Female

Male

Number of individuals

Unadjusted prevalence (%)

Mean age at first event (years)

?

Follow-up

Amount of time to look for the endpoint since entering the study. This is either either 1, 5, 15 years or the full study time from 1998 to 2019.

Absolute risk

Estimates the probability of dying from the current endpoint. Check the Documentation page for Mortality: absolute risk to get more details.

Hazard Ratio (HR) and 95% Confidence Interval (CI)

Measures how much the risk of dying increases (HR > 1) or decreases (HR < 1).

Number of individuals (N)

Number of individuals having the current endpoint and died during the follow-up time.
Mortality

Follow-up	Absolute risk	HR [95% CI]	p	N
1998–2019	-	-	-	-
15 years	-	-	-	-
5 years	-	-	-	-
1 year	-	-	-	-

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: D3_IMMUDEFPOSTEBV – Immunodeficiency following hereditary defective response to Epstein-Barr virus
GWS hits:

Survival analyses between endpoints

↥

Plot

before Immunodeficiency following hereditary defective response to Epstein-Barr virus
after Immunodeficiency following hereditary defective response to Epstein-Barr virus

Loading survival analyses plot

Table

Loading survival analyses table

Drugs most likely to be purchased after Immunodeficiency following hereditary defective response to Epstein-Barr virus

↥